Differential Responses to Challenge with Live and Dead Mycobacterium bovis Bacillus Calmette-Guérin

Journal of Immunology

Volumn 158, Issue 4, 1997, Pages 1742-1748

  Chambers, Mark A ^a,b   Marshall, Ben G ^a   Wangoo, Arun ^a   Bune, Alison ^a   Cook, H Terry ^a   Shaw, Rory J ^a   Young, Douglas B ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 1; LIVE VACCINE; NITRIC OXIDE SYNTHASE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL MOTION; CHEMISTRY; COMPARATIVE STUDY; DENDRITIC CELL; FEMALE; FOOT; HINDLIMB; IMMUNOLOGY; INFLAMMATION; LYMPH NODE; MICROBIOLOGY; MONONUCLEAR CELL; MOUSE; MYCOBACTERIUM BOVIS; PATHOLOGY; STAINING; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BCG VACCINE; CELL MOVEMENT; DENDRITIC CELLS; FEMALE; FOOT; HINDLIMB; INFLAMMATION; INJECTIONS, SUBCUTANEOUS; INTERFERON TYPE II; INTERLEUKIN-1; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS; NITRIC OXIDE SYNTHASE; STAINING AND LABELING; VACCINES, ATTENUATED;

EID: 0031568532     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Raviglione, M. C., D. E. Snider, Jr., and A. Kochi. 1995. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic [see comments]. JAMA 273:220.
2. Baily, G. V. 1980. Tuberculosis prevention trial, Madras. Indian J. Med. Res. 72:1.
3. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature [see comments]. JAMA 271:698.
4. Ponnighaus, J. M., P. E. Fine, J. A. Sterne, R. J. Wilson, E. Msosa, P. J. Gruer, P. A. Jenkins, S. B. Lucas, N. G. Liomba, and L. Bliss. 1992. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi [see comments]. Lancer 339:636.
5. Orme, I. 1988. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance, in mice inoculated with killed mycobacterial vaccines. Infect. Immun. 56:3310.
6. Freund, J., and G. Middlebrook. 1948. Tuberculosis. In Bacteriology and Mycotic Infection. R. J. Dubos, ed. Lippincott Co., Philadelphia, p. 303.
7. Blanden, R. V., M. J. Lefford, and G. B. Mackaness. 1969. The host response to Calmette-Guerin bacillus infection in mice. J. Exp. Med. 129:1079.
8. Andersen, P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:2536.
9. Horwitz, M. A., B. W. Lee, B. J. Dillon, and G. Harth. 1995. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 92:1530.
10. Pal, P. G., and M. A. Horwitz. 1992. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect. Immun. 60:4781.
11. Vordermeier, H. M., A. G. Coombes, P. Jenkins, J. P. McGee, D. T. O'Hagan, S. S. Davis, and M. Singh. 1995. Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38-kDa protein entrapped in biodegradable PLG microparticles. Vaccine 13:1576.
12. Hart, P. D., M. R. Young, A. H. Gordon, and K. H. Sullivan. 1987. Inhibition of phagosome-lysosome fusion in macrophages by certain mycobacteria can be explained by inhibition of lysosomal movements observed after phagocytosis. J. Exp. Med. 166:933.
13. Daugelat, S., C. H. Ladel, and S. H. Kaufmann. 1995. Influence of mouse strain and vaccine viability on T-cell responses induced by Mycobacterium bovis bacillus Calmette-Guerin. Infect. Immun. 63:2033.
14. Brown, C. A., I. N. Brown, and V. S. Sljivic. 1979. Phagosome/lysosome fusion: a possible prerequisite for the enhancement of antibody responses in vitro by BCG, Mycobacterium leprae and Corynebacterium parvum. Parasite Immunol. 1:309.
15. Lagrange, P. H., B. Hurtrel, and P. Ravisse. 1978. Delayed local reaction (DLR) after BCG vaccination in mice. I. Description [author's translation]. Ann. Immunol. Paris 129c:529.
16. Collins, F. M., L. Auclair, and V. Montalbine. 1975. Effect of T-cell depletion on the growth of BCG in the mouse footpad. Int. Arch. Allergy Appl. Immunol. 48:680.
17. Kvach, J. T., and J. R. Veras. 1982. A fluorescent staining procedure for determining the viability of mycobacterial cells. Int. J. Lepr. Other Mycobact. Dis. 50:183.
18. Gooding, H., and D. Stewart. 1932. A comparative study of histological preparations of bone which have been treated with different combinations of fixatives and decalcifying fluids. Lab. J. 7:55.
19. Kraal, G., M. Breel, M. Janse, and G. Bruin. 1986. Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J. Exp. Med. 163:981.
20. Cook, H. T., A. J. Bune, A. S. Jansen, G. M. Taylor, R. K. Loi, and V. Cattell. 1994. Cellular localization of inducible nitric oxide synthase in experimental endotoxic shock in the rat. Clin. Sci. 87:179.
21. Gerdes, J., M. H. Becker, G. Key, and G. Cattoretti. 1992. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues [letter] [see comments]. J. Pathol. 168:85.
22. Detre, S., G. Saclani Jotti, and M. Dowsett. 1995. A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J. Clin. Pathol. 48:876.
23. Kinyoun, J. J. 1915. A note on Uhlenhuth's method for sputum examination for tubercle bacilli. Am. J. Pub. Health 5:867.
24. Hume, D. A., A. P. Robinson, G. G. MacPherson, and S. Gordon. 1983. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs. J. Exp. Med. 158:1522.
25. Ezekowitz, R. A., J. Austyn, P. D. Stahl, and S. Gordon. 1981. Surface properties of bacillus Calmette-Guerin-activated mouse macrophages. Reduced expression of mannose-specific endocytosis. Fc receptors, and antigen F4/80 accompanies induction of Ia. J. Exp. Med. 154:60.
26. Assreuy, J., F. Q. Cunha, M. Epperlein, A. Noronha Dutra, C. A. O'Donnell, F. Y. Liew, and S. Moncada. 1994. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur. J. Immunol. 24: 672.
27. Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, J. Gerecitano, D. Shapiro, J. Le, S. I. Koh, T. Kimura, S. J. Green, T. W. Mak, T. Taniguchi, and J. Vilcek. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612.
28. Nussler, A. K., and T. R. Billiar. 1993. Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leukocyte Biol. 54:171.
29. Jiang, W., W. J. Swiggard, C. Heufler, M. Peng, A. Mirza, R. M. Steinman, and M. C. Nussenzweig. 1995. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375:151.
30. Swiggard, W. J., A. Mirza, M. C. Nussenzweig, and R. M. Steinman. 1995. DEC-205, a 205-kDa protein abundant on mouse dendritic cells and thymic epithelium that is detected by the monoclonal antibody NLDC-145: purification, characterization, and N-terminal amino acid sequence. Cell. Immunol. 165:302.
31. Winner-Pack, M. D., W. J. Swiggard, A. Mirza, K. Inaba, and R. M. Steinman. 1995. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. II. Expression in situ in lymphoid and nonlymphoid tissues. Cell. Immunol. 163:157.
32. Dunn, P. L., and R. J. North. 1991. Early gamma interferon production by natural killer cells is important in defense against murine listeriosis. Infect. Immun. 59: 2892.
33. Wolfe, S. A., D. E. Tracey, and C. S. Henney. 1977. BCG-induced murine effector cells. II. Characterization of natural killer cells in peritoneal exudates. J. Immunol. 119:1152.
34. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178:567.
35. Inoue, T., Y. Yoshikai, G. Matsuzaki, and K. Nomoto. 1991. Early appearing γδ-bearing T cells during infection with Calmette-Guerin bacillus. J. Immunol. 146:2754.
36. Cunha, F. Q., J. Assreuy, D. W. Moss, D. Rees, L. M. Leal, S. Moncada, M. Carrier, C. A. O'Donnell, and F. Y. Liew. 1994. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta. Immunology 81:211.
37. Allen, J. N., D. J. Herzyk, E. D. Allen, and M. D. Wewers. 1992. Human whole blood interleukin-1-beta production: kinetics, cell source, and comparison with TNF-alpha. J. Lab. Clin. Med. 119:538.
38. Yang, J., I. Kawamura, H. Zhu, and M. Mitsuyama. 1995. Involvement of natural killer cells in nitric oxide production by spleen cells after stimulation with Mycobacterium bovis BCG. Study of the mechanism of the different abilities of viable and killed BCG. J. Immunol. 155:5728.
39. Chensue, S. W., I. G. Otterness, G. I. Higashi, C. S. Forsch, and S. L. Kunkel. 1989. Monokine production by hypersensitivity (Schistosoma mansoni egg) and foreign body (Sephadex bead)-type granuloma macrophages. Evidence for sequential production of IL-1 and tumor necrosis factor. J. Immunol. 142:1281.
40. Kasahara, K., K. Kobayashi, Y. Shikama, I. Yoneya, K. Soezima, H. Ide, and T. Takahashi. 1988. Direct evidence for granuloma-inducing activity of interleukin-1. Induction of experimental pulmonary granuloma formation in mice by interleukin-1-coupled beads. Am. J. Pathol. 130:629.
41. Kasahara, K., K. Kobayashi, Y. Shikama, I. Yoneya, S. Kaga, M. Hashimoto, T. Odagiri, K. Soejima, H. Ide, T. Takahashi, and T. Yoshida. 1989. The role of monokines in granuloma formation in mice: the ability of interleukin 1 and tumor necrosis factor-alpha to induce lung granulomas. Clin. Immunol. Immunopathol. 51:419.
42. Kindler, V., A. P. Sappino, G. E. Grau, P. F. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731.
43. Kobayashi, K., C. Allred, S. Cohen, and T. Yoshida. 1985. Role of interleukin 1 in experimental pulmonary granuloma in mice. J. Immunol. 134:358.
44. Kobayashi, K., C. Allred, R. Castriotta, and T. Yoshida. 1985. Strain variation of bacillus Calmette-Guerin-induced pulmonary granuloma formation is correlated with anergy and the local production of migration inhibition factor and interleukin 1. Am. J. Pathol. 119:223.
45. Shikama, Y., K. Kobayashi, K. Kasahara, S. Kaga, M. Hashimoto, I. Yoneya, S. Hosoda, K. Soejima, H. Ide, and T. Takahashi. 1989. Granuloma formation by artificial microparticles in vitro. Macrophages and monokines play a critical role in granuloma formation. Am. J. Pathol. 134:1189.
46. Rook, G. A., J. Taverne, C. Leveton, and J. Steele. 1987. The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology 62:229.
47. Shellito, J., and H. B. Kaltreider. 1984. Heterogeneity of immunologic function among subfractions of normal rat alveolar macrophages. Am. Rev. Respir. Dis. 129:747.
48. Wewers, M. D., S. I. Rennard, A. J. Hance, P. B. Bitterman, and R. G. Crystal. 1984. Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1. J. Clin. Invest. 74:2208.
49. Chan, J., K. Tanaka, D. Carroll, J. Flynn, and B. R. Bloom. 1995. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Inject. Immun. 63:736.
50. Stuehr, D. J., and M. A. Marletta. 1987. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. J. Immunol. 139:518.
51. Green, S. J., C. A. Nacy, R. D. Schreiber, D. L. Granger, R. M. Crawford, M. S. Meltzer, and A. H. Fortier. 1993. Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice. Infect. Immun. 61:689.
52. Moll, H., H. Fuchs, C. Blank, and M. Rollinghoff. 1993. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur. J. Immunol. 23:1595.
53. Moll, H., S. Flohe, and M. Rollinghoff. 1995. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur. J. Immunol. 25:693.
54. Cumberbatch, M., and I. Kimber. 1992. Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology 75:257.
55. Enk, A. H., V. L. Angeloni, M. C. Udey, and S. I. Katz. 1993. An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. J. Immunol. 150:3698.
56. + epidermal dendritic cells but increases their expression of Ia antigen. Acta Derm. Venereol. 70:391.
57. Inaba, K., M. Inaba, M. Naito, and R. M. Steinman. 1993. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 178:479.
58. Pancholi, P., A. Mirza, V. Schauf, R. M. Steinman, and N. Bhardwaj. 1993. Presentation of mycobacterial antigens by human dendritic cells: lack of transfer from infected macrophages. Infect. Immun. 61:5326.
59. Inaba, K., W. J. Swiggard, M. Inaba, J. Meltzer, A. Mirza, T. Sasagawa, M. C. Nussenzweig, and R. M. Steinman. 1995. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes. Cell. Immunol. 163:148.